HighTower Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$686K Buy
7,367
+3,306
+81% +$293K ﹤0.01% 2462
2025
Q4
$326K Buy
4,061
+419
+12% +$35.1K ﹤0.01% 2979
2025
Q3
$356K Buy
3,642
+275
+8% +$22.1K ﹤0.01% 2899
2025
Q2
$235K Buy
+3,367
New +$192K ﹤0.01% 3145
2024
Q4
Sell
-3,666
Closed -$382K 3802
2024
Q3
$382K Buy
3,666
+697
+23% +$81.5K ﹤0.01% 2624
2024
Q2
$425K Buy
2,969
+227
+8% +$26.2K ﹤0.01% 2434
2024
Q1
$302K Sell
2,742
-606
-18% -$72.2K ﹤0.01% 2673
2023
Q4
$438K Sell
3,348
-1,401
-30% -$193K ﹤0.01% 2415
2023
Q3
$773K Buy
4,749
+1,000
+27% +$176K ﹤0.01% 1941
2023
Q2
$687K Buy
3,749
+690
+23% +$99.3K ﹤0.01% 1987
2023
Q1
$409K Buy
3,059
+26
+0.9% +$3.06K ﹤0.01% 2240
2022
Q4
$242K Buy
+3,033
New +$214K ﹤0.01% 2632

Other funds holding ACLS

HighTower Advisors's ACLS Position: Q1 2026 in Review

HighTower Advisors increased its Axcelis (ACLS) stake by 81% in Q1 2026, buying an estimated $293K and bringing the position to 7,367 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #2462.

HighTower Advisors first reported a position in ACLS in Q4 2022 and has held it in 12 quarters since. The position peaked at $773K in Q3 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • HighTower Advisors held 7,367 shares of Axcelis worth $686K as of Q1 2026.
  • HighTower Advisors bought 3,306 Axcelis shares in Q1 2026, an estimated $293K.
  • Axcelis made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2462 holding.
  • HighTower Advisors first reported a position in Axcelis in Q4 2022 and has held it in 12 quarters since.
  • HighTower Advisors's Axcelis position peaked at $773K in Q3 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.